XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Stockholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2024

Equity [Abstract]

Schedule of Share-Based Compensation Expense

The following table sets forth share-based compensation expense included in the condensed consolidated statements of operations:

			Three Months Ended June 30,
(in thousands)			2024						2023
Cost of revenue			$	29					$	27
Research and development			406						370
Sales and marketing			524						484
General and administrative			837						764
Share-based compensation expense			$	1,796					$	1,645

			Six Months Ended June 30,
(in thousands)			2024						2023
Cost of revenue			$	51					$	47
Research and development			743						652
Sales and marketing			945						847
General and administrative			1,561						1,406
Share-based compensation expense			$	3,300					$	2,952

Share-based compensation expense by type of share-based award is summarized below:

			Three Months Ended June 30,
(in thousands)			2024						2023
Stock options			$	195					$	266
RSAs and RSUs			1,540						1,312
ESPP			61						67
			$	1,796					$	1,645

			Six Months Ended June 30,
(in thousands)			2024						2023
Stock options			$	403					$	514
RSAs and RSUs			2,776						2,304
ESPP			121						134
			$	3,300					$	2,952

Total unrecognized compensation expense by type of award and the weighted-average remaining requisite holding period over which such expense is expected to be recognized (in thousands, unless otherwise noted):

			June 30, 2024
			Unrecognized Expense						Remaining Weighted-Average Recognition Period (in years)
Stock options			$	597					1.31
RSAs and RSUs			$	11,310					2.03

Schedule of Stock Option Activity

Stock option activity under the Company’s current and previous plans during the six months ended June 30, 2024 is summarized below:

			Stock Options						Weighted-average Exercise price per share						Weighted-average Remaining Contractual Life (in years)						Intrinsic Value(1) (in thousands)
Outstanding at December 31, 2023			1,478,157						$	8.40
Exercised			(11,000)						$	3.01
Forfeited or expired			(6,112)						$	42.82
Outstanding at June 30, 2024			1,461,045						$	8.30					4.99						$	2,183
Exercisable at June 30, 2024			1,302,175						$	8.03					4.60						$	2,183
Vested and expected to vest at June 30, 2024			1,461,045						$	8.30					4.99						$	2,183

(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.

Schedule of Restricted Stock Activity

Restricted stock award ("RSA") activity for the six months ended June 30, 2024 is summarized below:

						Restricted Stock Awards						Weighted - Average Grant Date Fair Value
Outstanding at December 31, 2023						376,914						$	12.02
Vested						(147,197)						$	11.76
Forfeited						(3,679)						$	12.11
Outstanding at June 30, 2024						226,038						$	12.18

Restricted Stock Unit Activity

Restricted stock unit ("RSU") activity for the six months ended June 30, 2024 is summarized below:

						Restricted Stock Units						Weighted - Average Grant Date Fair Value
Outstanding at December 31, 2023						768,139						$	8.15
Granted						1,192,622						$	6.16
Vested						(260,441)						$	8.06
Forfeited						(12,911)						8.52
Outstanding at June 30, 2024						1,687,409						$	6.76

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration